-
PFIZER INC. v. MYLAN LABORATORIES, et al DC CAFC
- 2:02-cv-01628
- W.D. Pa.
- Judge: Terrence F. McVerry
- Filed: 09/20/2002
- Closed: 02/27/2007
- Latest Docket Entry: 06/30/2008
- PACER
- Docket updated daily
1
Plaintiff
2
Defendants
0
Accused
Products
2
Patents-in-Suit
1,622
Days in
Litigation
-
PFIZER INC. v. MYLAN LABORATORIES, et al DC CAFC
- 2:02-cv-01628
- W.D. Pa.
- Judge: Terrence F. McVerry
- Filed: 09/20/2002
- Closed: 02/27/2007
- Latest Docket Entry: 06/30/2008
- PACER
- Docket updated daily
Complaint Unavailable
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
1 |
The besylate salt of amlodipine.
|
Enforceable and Valid
Entry 233 |
2 |
A pharmaceutical composition comprising an antihypertensive, antiischaemic or angina - alleviating effective amount of the besylate salt of amlodipine as claimed in claim 1 together with a pharmaceutically acceptable diluent or carrier.
|
Enforceable and Valid
Entry 233 |
3 |
A tablet formulation comprising an anti-hypertensive, antiischaemic or angina - alleviating effective amount of the besylate salt of amlodipine as claimed in claim 1 in admixture with excipients.
|
Enforceable and Valid
Entry 233 |
-
Infringement
Mylan Laboratories Incorporated
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
amlodipine besylate tablets, 2.5, 5 and 10 mg dosage strengthsGeneric amlodipine besylate tablets, 10 mg dosage strengthGeneric amlodipine besylate tablets, 2.5 mg dosage strengthGeneric amlodipine besylate tablets, 5 mg dosage strength | US 4,879,303 A |
1, 2, 3
|
Infringement
Entry 248Entry 233 |
Mylan Pharmaceuticals Incorporated
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
amlodipine besylate tablets, 2.5, 5 and 10 mg dosage strengthsGeneric amlodipine besylate tablets, 10 mg dosage strengthGeneric amlodipine besylate tablets, 2.5 mg dosage strengthGeneric amlodipine besylate tablets, 5 mg dosage strength | US 4,879,303 A |
1, 2, 3
|
Infringement
Entry 248Entry 233 |